Delivery Order SPE2DB20D2002-SPE2DB23FL65D
Award Date
8/28/23
Potential Completion Date
8/29/23
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,694.10, is for the delivery of Lidocaine 5% Patches. This is a firm fixed-price delivery order contract with a completion date of February 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,465.18 and runs through May 7, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of Defense (DoD)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,535.82, is for the delivery of Lidocaine 5% Patches and is a firm-fixed price delivery order with a completion date of January 23, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% patches. The $1,625.88 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary mechanism for Amerisourcebergen to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,729.60 firm fixed-price delivery order is for Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, and has a ceiling value of $5,321.09. The contract has a performance period through February 6, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $8,939.95, is for the delivery of Lidocaine 5% patches. It is a firm-fixed-price delivery order with a completion date of November 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,073.70, is for the delivery of Lidocaine 5% Patches and has a completion date of December 6, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
This federal contract award, valued at $1,652.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lidocaine 5% Patch 30S. The contract, valued at $12,422.33, has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...